1. Home
  2. NVCR vs OI Comparison

NVCR vs OI Comparison

Compare NVCR & OI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • OI
  • Stock Information
  • Founded
  • NVCR 2000
  • OI 1903
  • Country
  • NVCR Switzerland
  • OI United States
  • Employees
  • NVCR N/A
  • OI N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • OI Containers/Packaging
  • Sector
  • NVCR Health Care
  • OI Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • OI Nasdaq
  • Market Cap
  • NVCR 1.9B
  • OI 1.8B
  • IPO Year
  • NVCR 2015
  • OI N/A
  • Fundamental
  • Price
  • NVCR $17.59
  • OI $13.26
  • Analyst Decision
  • NVCR Buy
  • OI Buy
  • Analyst Count
  • NVCR 6
  • OI 8
  • Target Price
  • NVCR $32.83
  • OI $15.50
  • AVG Volume (30 Days)
  • NVCR 861.0K
  • OI 1.4M
  • Earning Date
  • NVCR 04-24-2025
  • OI 04-29-2025
  • Dividend Yield
  • NVCR N/A
  • OI N/A
  • EPS Growth
  • NVCR N/A
  • OI N/A
  • EPS
  • NVCR N/A
  • OI N/A
  • Revenue
  • NVCR $621,711,000.00
  • OI $6,505,000,000.00
  • Revenue This Year
  • NVCR $2.90
  • OI $1.19
  • Revenue Next Year
  • NVCR $10.47
  • OI $1.15
  • P/E Ratio
  • NVCR N/A
  • OI N/A
  • Revenue Growth
  • NVCR 18.27
  • OI N/A
  • 52 Week Low
  • NVCR $14.17
  • OI $9.23
  • 52 Week High
  • NVCR $34.13
  • OI $15.72
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 48.61
  • OI 66.20
  • Support Level
  • NVCR $16.19
  • OI $12.80
  • Resistance Level
  • NVCR $18.52
  • OI $13.49
  • Average True Range (ATR)
  • NVCR 0.85
  • OI 0.47
  • MACD
  • NVCR 0.06
  • OI 0.17
  • Stochastic Oscillator
  • NVCR 54.82
  • OI 85.66

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

Share on Social Networks: